[1]
Lotfi, S. 2023. Identification of Deferasirox as a Potential Carbonic Anhydrase II Inhibitor for Glaucoma treatment via Virtual Screening. Journal of Ophthalmic and Optometric Sciences. 6, 1 (Nov. 2023), 28–41. DOI:https://doi.org/10.22037/joos.v6i1.42856.